Concepedia

Cian Stutz

CS

5

Publications

128

Citations

5

H-Index

2015

Active since

Affiliations

Glenmark Pharmaceuticals (Switzerland)(Current)

Glenmark Pharmaceuticals (India)

Cian Stutz is an author at Glenmark Pharmaceuticals (Switzerland) specializing in cell biology, medicine, and molecular biology.

ORCID

Top concepts

Publications per year

2015–2021

5

Publications

5

Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies

Darko Skegro, Cian Stutz, Romain Ollier et al. · Journal of Biological Chemistry · 2017 · 46 citations · Full text

Minishelterins separate telomere length regulation and end protection in fission yeast

Lili Pan, Katie Hildebrand, Cian Stutz et al. · Genes & Development · 2015 · 23 citations · Full text

, , +13

Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and development

Romain Ollier, Paul Wassmann, Thierry Monney et al. · mAbs · 2019 · 22 citations · Full text

A single mutation increases heavy-chain heterodimer assembly of bispecific antibodies by inducing structural disorder in one homodimer species

Cian Stutz, Stanislas Blein · Journal of Biological Chemistry · 2020 · 20 citations · Full text

ISB 1342: A first-in-class CD38 T cell engager for the treatment of relapsed refractory multiple myeloma.

Marie‐Agnès Doucey, Blandine Pouleau, Carole Estoppey et al. · Journal of Clinical Oncology · 2021 · 17 citations

, , +20

Rows per page

1–5 of 5